Cumberland Pharmaceuticals Inc

Ownership Transactions Reported by 15 Insiders

Symbol
CPIX on Nasdaq
Location
2525 West End Avenue, Suite 950, Nashville,, TN

Insiders trading volume in the past year

Cumberland Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
A. J. Kazimi Chairman and CEO, Director, 10%+ Owner $8.16M +$3.58K +0.04% Nov 1, 2024
Kenneth Krogulski Director $359K +$18.5K +5.43% Nov 1, 2024
Martin E. Cearnal Sr VP/Chief Commercial Officer, Director $278K Mar 17, 2022
Leo Pavliv SVP and Chief Development Off. $220K May 31, 2022
Joey A. Jacobs Director $167K Jan 14, 2023
Joseph C. Galante Director $101K Mar 25, 2024
James L. Herman VP and Chief Compliance Office $96.6K Mar 23, 2024
John Hamm VP Chief Financial Officer $68.4K Mar 23, 2024
Todd M. Anthony Vice Pres Organizational Dev $55.2K Mar 23, 2024
James Jones Director $52K +$3.58K +7.4% Nov 1, 2024
Caroline Young Director $39.2K +$1.67K +4.45% Nov 1, 2024
Chris T. Bitterman Vice Pres Sales & Marketing $31.1K Mar 23, 2024
Jonathan Griggs Director $25.2K Mar 17, 2021
Michael Bonner Chief Financial Officer $19.9K Mar 17, 2021
Martin S. Brown JR Director $10.3K Mar 25, 2024

Recent Insider Transactions by Companies or Individuals for Cumberland Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.